What is the last grey market premium of Influx Healthtech IPO?

 Click

Listing Review: Will update on listing.

Subscription status of Influx Healthtech IPO

Influx Healthtech IPO
(Day 1)

Price Rs. 96 Lot 1200 shares, Rs.58.57 Crore

QIB NII x RII x Total x Applications
         
Note:

Influx Healthtech IPO Allotment Link: 

 

What is the business of Influx Healthtech?

Influx Healthtech Limited is a Mumbai-based, healthcare focused company specialising in contract manufacturing. Since its inception in 2020, the company has established itself as a reliable Contract Development and Manufacturing Organization (CDMO), offering specialized services to a wide range of clients across various industries.

The company operates manufacturing facilities located in Thane, Maharashtra, covering a total area of approximately 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively. These facilities are certified to international quality standards, including GMP (Good Manufacturing Practice), HACCP (Hazard Analysis & Critical Control Points), ISO 22000, and Halal certifications, ensuring adherence to the highest standards of safety, quality and regulatory compliance.

Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables.

Its product portfolio includes dietary and nutritional supplements in various forms:

  • Tablets, Capsules, and Powders
    • Liquid Orals and Softgels
    • Lozenges, Jellies, and Gummies
    • Oral Dispersible Films (ODFs)
    • Effervescent Tablets and Liquid-Fill Capsules
    • Candies and Gym/Sports Supplements
    The company also manufactures a diverse range of cosmetic products for men and women, including:
    • Skin Care and Body Care Products
    • Hair Care and Beard Care Solutions
    • Face Masks and Soaps
    The company also manufactures ayurvedic and herbal formulations.
    Its veterinary feed supplements are available in multiple formats, designed for animals such as dogs, cats, horses, birds, cows, chickens, pigs, buffaloes, squirrels, and goats.
    The company also manufactures a variety of homecare solutions

Get more information about the company @ www.influxhealthtech.com

Influx Healthtech IPO Details

Sector: Healthcare

IPO opens on  18 June 2025
IPO closes on  20 June 2025
Issue Type Book Built Issue IPO
Issue Size 6100,800 Shares /
Rs 58.57 Crore
* Fresh Issue 5000,400 Shares /
Rs 48.00 Crore
* Offer for Sale – 1100,400 Shares/
Rs. 10.56 Crore
Market Maker Portion 306,000 Shares
Net offer to Public 5794,800 Shares
Rs.55.63 Crores
Face Value per share Rs. 10
Price Band Rs. 91-96
Employee discount  Rs. 0 per share
Retail Lot Size  1200 Shares
Listing will at  NSE SME

Shares offered in IPO

  Shares Rs. (Crore)
QIB (50%) 2897400 27.82
HNI (15%)   869220   8.34
RII  (35%) 2028180 19.47
Total Shares  5794800 55.63
Retail portion will be
oversubscribed by 
1690
Forms
How much Shares to Apply in this IPO?
Min Retail Application 1200 Shares Rs.115200
Min HNI Application  2400 Shares Rs.230400

Who are the Promoters of Influx Healthtech?

The promoters of the company are Mr. Munir Abdul Ganee Chandniwala, Mrs. Shirin Munir Ahmed Chandniwala and Mr. Abdul Ganee Abdul Rasul Chandniwala.

What are the Objects of Influx Healthtech IPO?

a) Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division Rs. 22.60 crores

b) Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division Rs. 11.59 Crores

c) Purchase of Machineries for Homecare and Cosmetic Division Rs. 2.76 Crore

d) General corporate purposes

Tentative timetable

IPO opens on 18 June 2025
IPO Closes on 20 June 2025
IPO Allotment on  23 June 2025
Refund Initiation  24 June 2025
Credit of Shares 24 June 2025
Listing on 25 June 2025
Registered Office of the Company
Influx Healthtech Limited
109, Ghanshyam Enclave Premises Co-op
Soc Plot No. 856, Laljipada
Kandivali West,
Mumbai, Maharashtra
The Lead Manager of this IPO
Rarever Financial Advisors Pvt ltd

Who is the Registrar to IPO?

Maashitla Securities Pvt ltd

Influx Healthtech IPO GMP grey market premium, review, Subscription, allotment, listing estimate

Influx Healthtech Financials

Period Ended 31-Mar-25 31-Mar-24 31-Mar-23
Assets 70.3 41.1 28.3
Revenue 104.99 100.1 76.07
Profit After Tax 13.37 11.22 7.2
Net Worth 36.15 22.87 11.65
Reserves and Surplus 18 22.85 11.63
Total Borrowing 0.22 0.32 0.8
Amount in Rs. Crore

Performance Indicators

KPI Values
ROE 36.98%
ROCE 49.17%
Debt/Equity 0.01
RoNW 36.98%
PAT Margin 12.75
Price to Book Value 7.62
EPS Rs. 7.36
PE Ratio 13.04

 

How Influx Healthtech IPO compares with the Peers?

Company Name P/E (x) P/BV Ratio
Sudarshan Pharma Industries Ltd 48.28 6.2
Quest Laboratories Limited 10.38 1.73
Influx Healthtech 13.04 7.62

# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

Influx Healthtech IPO Review by Paresh Gordhandas, CA & Research Analyst.

Will provide our guidance one the price band is announced.

+ from fundamental angle:  

+ from grey market angle: 

Quicklinks


 
Influx Healthtech IPO

 
Influx Healthtech IPO

Leave a Reply

Your email address will not be published. Required fields are marked *